Sabine Eichinger
Department of Internal Medicine I
University Vienna
Austria
Name/email consistency: high
- Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. Eichinger, S., Schönauer, V., Weltermann, A., Minar, E., Bialonczyk, C., Hirschl, M., Schneider, B., Quehenberger, P., Kyrle, P.A. Blood (2004)
- Prevention of deep vein thrombosis in orthopedic surgery. Eichinger, S., Kyrle, P.A. Eur. J. Med. Res. (2004)
- D-dimer levels and risk of recurrent venous thromboembolism. Eichinger, S., Minar, E., Bialonczyk, C., Hirschl, M., Quehenberger, P., Schneider, B., Weltermann, A., Wagner, O., Kyrle, P.A. JAMA (2003)
- The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Eichinger, S., Weltermann, A., Mannhalter, C., Minar, E., Bialonczyk, C., Hirschl, M., Schönauer, V., Lechner, K., Kyrle, P.A. Arch. Intern. Med. (2002)
- Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Eichinger, S., Weltermann, A., Philipp, K., Hafner, E., Kaider, A., Kittl, E.M., Brenner, B., Mannhalter, C., Lechner, K., Kyrle, P.A. Thromb. Haemost. (1999)









